Phase II Trial of Weekly Docetaxel (Taxotere®) and Monthly Cisplatin Chemotherapy as Adjuvant Treatment for Patients With Completely Resected Non-small Cell Lung Cancer
Latest Information Update: 23 Jan 2019
At a glance
- Drugs Cisplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 15 Jan 2019 Status changed from active, no longer recruiting to completed.
- 17 Jul 2007 Status changed changed from recruiting to in progress.
- 23 Aug 2006 New trial record.